ACTIVE SUBSTANCE

Abobotulinumtoxina Acarbose Adalimumab Adipotide Albuterol Alpha-Melanocyte Alfuzosin Amiodarone Amlodipine Amoxycillin Amoxycillin Clavulanate Amoxycillin Trihydrate Anastrozole Anti-Obesity Drug-9604 Atorvastatin Avanafil Azithromycin Bacteriostatic Water Betamethasone Betahistine Betamethasone valerate Bimatoprost Boldenone Undecylenate BPC-157 Bremelanotide Bromocriptine Cabergoline Candesartan Cilexetil Cefalexin Cefdinir Cefixime Cefuroxime Ciprofloxacin Chlorodehydro Methyltest Clarithromycin Clenbuterol Clobetasol Propionate Clomiphene Citrate Clopidogrel Colecalciferol Cyproterone Dabigatran Dapoxetine Delta sleep-inducing peptide Desloratadine Diclofenac Potassium Dihydroboldenone Cypionate Diosmina Donnazyme Doxazosin Doxycycline Hyclate Drospirenone Drostanolone Di-Propionat Drostanolone Enanthate Drostanolone Propionate Duloxetine Dutasteride Dydrogesterone ED & PE Mixes Enoxaparin Sodium Epitalon Erythropoietin Esomeprazole Etanercept Ethinyl Estradiol Examorelin Exemestane Finasteride Flibanserin Fluoxetine Fluoxymesterone Fluticasone Furosemide Gemifloxacin Mesylate GHRH Peptide GHRP Peptide Ginseng Gliclazide Gonadorelin Growth Hormone peptide fragment 176-191 GW1516 Herbal Mix Hesperidina Human Chorionic Gonadotropin Human Menopausal Gonadotropin Human Insulin Hyaluronic acid Hydrochloride Hydrochlorothiazide Hydroquinone Hydroxychloroquine Hydroxyzine Ibuprofen IGF-1LR3 Imiquimod Immune globulin Insulin Insulin Glargine Insulin Glulisine Insulin Isophane Insulin Lispro Insulin Lispro Protamine Suspension Ipamorelin Ipratropium Bromide Isotretinoin Ketotifen L-Ornithine L-Aspartate Lacidipine Lansoprazole Leflunomide Letrozole Levofloxacin Lidocaine Losartan Levothyroxine Sodium Liothyronine Sodium Lisinopril Mebeverine Hydrochloride Mechano Growth Factor Melanocyte-stimulating hormone (MSH) Mesterolone Metformin Metformin Hydrochloride Methandienone Methenolone Acetate Methenolone Enanthate Methimazole Methyl-1- Testosterone Methyldrostanolone Methyltrienolone Metoprolol Metronidazole Miconazole Nitrate Montelukast Sodium Moxifloxacin Multivitamin Nandrolone Decanoate Nandrolone Phenylpropionate Nandrolone Propionate Nandrolone Undecanoate Onabotulinumtoxina Orlistat Oxandrolone Oxymetholone Oxytocin Pimecrolimus Pioglitazone Pegylated Mechano Growth Factor Penicillin Perindopril Arginine Prednisolone Pyridostigmine Pyridoxine Raloxifene Retinoic Acid Rho(D) immune globulin Rivaroxaban Rosuvastatin Safed Musli Salmeterol Selank Semax Sibutramine Sildenafil Silymarin Sitagliptin Sodium Hyaluronate Sodium fusidat Solifenacin Somatropine - 191 Amino Acid Spiramycin Spironolactone Stanozolol Stanozolol Suspension T3 Triiodothyronine Tadalafil Tamoxifen Citrate Telmisartan Testosterone Acetate Testosterone Base Testosterone Cypionate Testosterone Decanoate Testosterone Enanthate Testosterone Gel Testosterone Isocaproate Testosterone Phenylpropionate Testosterone Propionate Testosterone Suspension Testosterone Undecanoate Thiamine Thiocolchicoside Thymosin beta-4 Ticagrelor Tioconazole Tiotropium bromide Tolterodine Toremifene Citrate Trenbolone Acetate Trenbolone Base Trenbolone Blend Trenbolone Enanthate Trenbolone Hexahydrobenzylcarbonate Trenbolone Suspension Triamterene Hydrochlorothiazide Triptorelin Udenafil Ursodeoxycholic acid Valacyclovir Valproic Acid Valsartan Vardenafil Varenicline Vitamin A Vitamin B1 Vitamin B2 Vitamin B3 Vitamin B5 Vitamin B6 Vitamin B9 Vitamin B12 Vitamin C Vitamin D Vitamin E Vitamin K1 Yohimbine Zinc Sulfate

discreet

EVISTA

Customer Reviews Shipping options
$45.00

Characteristics

ACTIVE HALF-LIFE
24 hours
Classification
SERM
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
Active Substance
FORM
28 pills x 60 mg
Manufacturer

Description

 

EVISTA 60mg - DAIICHI SANKYO

 

Evista is Daiichi Sankyo's brand name for raloxifen hydrochloride, a second-generation Selective Estrogen Receptor Modulator (SERM) in the benzothiophene family. On September 13, 2007, the U. S. Food and Drug Administration approved Evista for reduction in the risk of invasive breast cancer in postmenopausal women with and without osteoporosis. It has also been approved as a potent stand-alone osteoporosis treatment.
 
Essentially Evista is a non-steroidal, anti-estrogenic drug that possesses both estrogen agonist and antagonist properties. This means that how it acts estrogen promoting with regard to bones, or anti-estrogenic towards uterine and breast tissue depends on the absorption site, i.e. which receptors within the body are absorbing it.

Form

Evista, and raloxifene hydrochloride in general, is most often found in the form of 60 mg tablets. One tablet should be taken daily with or without food. If a dose is missed, take it as soon as it is remembered. However, if it is almost time for the next dose, skip the missed dosage and take only the next regularly scheduled dose. Do not take two doses at the same time.

Indications/Purpose

For bodybuilding/athletic purposes, within the male body, Evista primarily acts as an anti-estrogen. Aromatization is the process by which excess testosterone is readily converted to excess estrogen, which when absorbed by various estrogen receptors throughout the body can incite numerous negative side effects the most hazardous of which is probably gynecomastia (gyno) the development of female breast tissue in men, a condition caused by an imbalance in the testosterone to estrogen ratio.
 
Evista's actions are very similar to those of more popular anti-estrogens frequently used within the anabolic steroid community such as Tamoxifen (Nolvadex) and Clomiphene Citrate (Clomid), two drugs that effectively block estrogens absorption because they are preferred by the estrogen receptors. Anabolic steroid using bodybuilders and athletes take these drugs to prevent said estrogen absorption, causing it to instead continue circulating ineffectively throughout the bloodstream. Estrogens lack of absorption significantly reduces estrogenic side effects, as well as prohibits gynos development by starving existing gyno growth of the nourishing estrogen necessary to sustain and/or increase it. Without access to estrogen gyno shrinks, and in most cases completely dissolves resulting in full resolution. In a small percentage of cases the growth persists, but shrinks substantially and remains susceptible to redevelopment in subsequent steroid cycles if not properly protected against.

Side Effects

There are a host of Daiichi Sankyo cited major possible side effects (of course for women only as per this drugs prescription population), but most are manufacturer safeguards like blood clots, stroke and death from either complication. For the male steroid user, Evista possesses potential for the same major side effects but of course the relatively minor ones are far more common such as irritability, mood swings, joint stiffness or pain, temporarily negative lipid panel & hepatic results, and possible libido hindrance.

Additional Information
 
Evista is typically administered after anabolic steroid cycles including Stanozolol, Anavar, Primobolan, testosterone (propionate, enanthate, and cypionate), Trenbolone, Oral Turinabol, Deca-Durabolin, and Halotestin. This is called Post-Cycle Therapy (PCT), a process that bridges the time between cycle discontinuation and the restoration of HPTA.

Customer Reviews


Ironlust
06.10.2018
Rating: EXCELLENT
Verified Purchase
6 days in and it definetly seems to be reducing my gyno a bit already. Got some bunk ugl arimidex from a different source before i found PharmaComStore...big mistake

Only going with PharmaComStore for ancillaries in the future and probably gear too
Back to top